Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20200825048515N72Phase 2Completed
Phase 2, randomised, double-blind trial in coronary arteriosclerosis comparing Gabapentin with Paracetamol (2 arms). Primary endpoints: Blood pressure, Heart beat and 4 more. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20200825048515N72.